376 related articles for article (PubMed ID: 28707079)
1. Down-regulation of miR-23a inhibits high glucose-induced EMT and renal fibrogenesis by up-regulation of SnoN.
Xu H; Sun F; Li X; Sun L
Hum Cell; 2018 Jan; 31(1):22-32. PubMed ID: 28707079
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of microRNA-93 inhibits TGF-β1-induced EMT and renal fibrogenesis by down-regulation of Orai1.
Ma J; Zhang L; Hao J; Li N; Tang J; Hao L
J Pharmacol Sci; 2018 Apr; 136(4):218-227. PubMed ID: 29551286
[TBL] [Abstract][Full Text] [Related]
3. miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN.
Ai K; Zhu X; Kang Y; Li H; Zhang L
Exp Mol Pathol; 2020 Feb; 112():104358. PubMed ID: 31836508
[TBL] [Abstract][Full Text] [Related]
4. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
[TBL] [Abstract][Full Text] [Related]
5. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice.
Zhao Y; Yin Z; Li H; Fan J; Yang S; Chen C; Wang DW
Aging Cell; 2017 Apr; 16(2):387-400. PubMed ID: 28127848
[TBL] [Abstract][Full Text] [Related]
6. Oxymatrine Inhibits Renal Tubular EMT Induced by High Glucose via Upregulation of SnoN and Inhibition of TGF-β1/Smad Signaling Pathway.
Liu L; Wang Y; Yan R; Li S; Shi M; Xiao Y; Guo B
PLoS One; 2016; 11(3):e0151986. PubMed ID: 27010330
[TBL] [Abstract][Full Text] [Related]
7. Let-7d miRNA prevents TGF-β1-induced EMT and renal fibrogenesis through regulation of HMGA2 expression.
Wang Y; Le Y; Xue JY; Zheng ZJ; Xue YM
Biochem Biophys Res Commun; 2016 Oct; 479(4):676-682. PubMed ID: 27693697
[TBL] [Abstract][Full Text] [Related]
8. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy.
Gao BH; Wu H; Wang X; Ji LL; Chen C
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1338-1349. PubMed ID: 32096183
[TBL] [Abstract][Full Text] [Related]
9. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
[TBL] [Abstract][Full Text] [Related]
10. Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN.
Wang Y; Zhang X; Mao Y; Liang L; Liu L; Peng W; Liu H; Xiao Y; Zhang Y; Zhang F; Shi M; Liu L; Guo B
Exp Mol Pathol; 2020 Apr; 113():104375. PubMed ID: 31917288
[TBL] [Abstract][Full Text] [Related]
11. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
12. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
[TBL] [Abstract][Full Text] [Related]
13. SnoN upregulation ameliorates renal fibrosis in diabetic nephropathy.
Liu L; Shi M; Wang Y; Zhang C; Su B; Xiao Y; Guo B
PLoS One; 2017; 12(3):e0174471. PubMed ID: 28350874
[TBL] [Abstract][Full Text] [Related]
14. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy.
Liu H; Wang X; Liu S; Li H; Yuan X; Feng B; Bai H; Zhao B; Chu Y; Li H
Int J Biochem Cell Biol; 2016 Jan; 70():149-60. PubMed ID: 26646104
[TBL] [Abstract][Full Text] [Related]
15. The downregulation of SnoN expression in human renal proximal tubule epithelial cells under high-glucose conditions is mediated by an increase in Smurf2 expression through TGF-β1 signaling.
Li X; Diao Z; Ding J; Liu R; Wang L; Huang W; Liu W
Int J Mol Med; 2016 Feb; 37(2):415-22. PubMed ID: 26743567
[TBL] [Abstract][Full Text] [Related]
16. lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy.
Meng Q; Zhai X; Yuan Y; Ji Q; Zhang P
Braz J Med Biol Res; 2020; 53(4):e9288. PubMed ID: 32294702
[TBL] [Abstract][Full Text] [Related]
17. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
[TBL] [Abstract][Full Text] [Related]
18. TAK1 may promote the development of diabetic nephropathy by reducing the stability of SnoN protein.
Wang Y; Mao Y; Zhang X; Liu H; Peng W; Liang L; Shi M; Xiao Y; Zhang Y; Zhang F; Yan R; Guo B
Life Sci; 2019 Jul; 228():1-10. PubMed ID: 31028803
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis.
Liu B; Qiang L; Wang GD; Duan Q; Liu J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3478-3486. PubMed ID: 31081103
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial-to-mesenchymal transition by targeting miR-27b-3p and ZEB1 in diabetic nephropathy.
Wang X; Xu Y; Zhu YC; Wang YK; Li J; Li XY; Ji T; Bai SJ
J Cell Physiol; 2019 Aug; 234(8):12926-12933. PubMed ID: 30549040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]